laboratori corpor
remain bullish lh follow solid mark better expect
core lab trend impress margin expans covanc strong cash flow
strateg capit deploy guidanc nudg pama pressur
remain head wind expect build opportun around share gain
acceler addit view lh uniqu posit world
move toward increas transpar cost-effect care valu
continu like power combin model reiter buy
rais target vs ep vs prior
bullish labcorp like compani posit within diagnost lab
space found sever encourag data point result organ
revenu growth exclud busi sale foreign currenc despit
head wind impact pama organ volum grew
ex biz sale despit one fewer revenu day manag care
contract chang aid strong core trend weather
share gain aetna would also highlight lh exclud volum
hospit lab manag agreement would taken organ
volum better expect core trend less impact recent
manag care contract chang industri dynam inher favor
larger sophist player like lh leav compani well posit
expect impact pama disproportion wound smaller provid
drive acceler share gain/m opportun addit
expect move toward narrow network focu valu
continu like drive on-going share shift toward lh final
custom increasingli spend money push toward increas
transpar intens focu provid offer low-cost high qualiti
servic like continu rise remain bullish lh view compani
strateg posit enviabl reiter buy rais pt
covanc post anoth solid quarter organ revenu in-lin lh
launchpad meaning margin expans result boast
margin expans adjust oper incom growth net order
net-book-to-bil ttm backlog current stand
expect convert revenu next month
tr target
laboratori corpor america hold
manag also provid addit detail envigo recent busi swap transact
lh non-clin research capabl multi-year suppli agreement provid on-going
access envigo model servic envigo deal bring attract rel margin expect
accret earn cash flow year yield synergi first two
year exceed cost capit year deal also bring cross-sel opportun broaden
footprint/servic offer provid addit capac
walgreen hold partnership continu make notic progress track
least locat end least locat expect
focu consum access conveni help drive increment volum growth higher patient
satisfact think partnership offer opportun expand healthcar servic
offer lh also plan add consum initi phlebotomy-bas test pixel
labcorp broaden test option expand number patient reach
home like improv patient satisfact also expect lh suit digit solut
labcorp express labcorp pre-check labcorp patient drive on-going oper improv
patient satisfact labcorp express standard labcorp walgreen site final
earli day commentari around combin potenti lh/wba cro opportun intrigu
given two compani combin scale signific lab script data sizabl global footprint
see potenti meaning opportun time
trend strong expect on-going deploy cffo
came bit ahead compani continu gener strong
cash flow effect deploy capit quarter lh bought back stock
spent acquisit flexibl remain high net-debt ttm adjust ebitda
run addit expect industri dynam pama narrow network drive
ongoing/potenti acceler smaller provid increasingli struggl
guidanc estim updat full year adjust ep guidanc nudg modestli
vs prior revenu guidanc diagnost divis covanc overal
revenu growth unchang addit free cash flow guidanc also
unchang bump adjust ep
respect reiter buy rate rais price target
page
laboratori corpor america hold
servic
revenu
incom equiti invest
revenu
laboratori corpor america mm
page
laboratori corpor america hold
headquart burlington nc laboratori corpor america hold labcorp one
largest independ clinic laboratori broad offer includ routin test
blood chemistri urinalys pap hiv substance-abus etc specialti test oncolog hiv
genotyp phenotyp diagnost genet clinic research trial compani also
oper cro busi extend servic offer includ clinic research provid
meaning intern presenc chiltern acquisit meanin expand cro servic
clinic lab remain integr part healthcar deliveri model diagnost test critic
compon treatment decis process combin covanc busi lh boast
signific scale divers servic offer uniqu posit area person medicin
potenti risk-bas reimburs system diversifi revenu stream custom
base also meaning lower reimburs risk one custom repres revenu
govern pay addit signific clinic horsepow geograph
diversif provid platform addit growth opportun time rate share
valuat risk
price target base stock trade adjust ep premium
current multipl given labcorp sizabl esoter presenc solid cash flow gener
attract cross-sel opportun covance/chiltern view appropri addit
believ effici initi aggress focu cost control could provid
support risk rate price target includ advers shift reimburs pama poor
integr acquisit pressur econom uncertainti perform covanc
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
